BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11436043)

  • 1. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.
    Fung M; Loubser PG; Undar A; Mueller M; Sun C; Sun WN; Vaughn WK; Fraser CD
    J Thorac Cardiovasc Surg; 2001 Jul; 122(1):113-22. PubMed ID: 11436043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-factor D monoclonal antibody, pulsatile flow and cardiotomy suction during cardiopulmonary bypass.
    Undar A; Fraser CD
    Eur J Cardiothorac Surg; 2002 Aug; 22(2):330-1; author reply 331. PubMed ID: 12142218
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
    Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
    J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C3 cleavage in monocyte activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Johnson K; Smith M; Lee DL; Tracey J; Polack G; Higgins P; Yeh CG; Smith BR
    Circulation; 1999 Aug; 100(5):553-8. PubMed ID: 10430771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses.
    Rinder C; Fitch J
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S6-12. PubMed ID: 8938278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation.
    Rinder CS; Smith MJ; Rinder HM; Cortright DN; Brodbeck RM; Krause JE; Smith BR
    Ann Thorac Surg; 2007 Jan; 83(1):146-52. PubMed ID: 17184649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass.
    Undar A; Eichstaedt HC; Clubb FJ; Fung M; Lu M; Bigley JE; Vaughn WK; Fraser CD
    Ann Thorac Surg; 2002 Aug; 74(2):355-62; discussion 362. PubMed ID: 12173813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass.
    Finn A; Morgan BP; Rebuck N; Klein N; Rogers CA; Hibbs M; Elliott M; Shore DF; Evans TW; Strobel S; Moat N
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):451-9. PubMed ID: 8583820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APT070 inhibits complement activation during in vitro cardiopulmonary bypass.
    De Silva RJ; Vuylsteke A; Fritchley SJ; Trull AK; Dunning JJ; Wallwork J
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):72-6. PubMed ID: 16723247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
    Kanemitsu S; Nishikawa M; Onoda K; Shimono T; Shimpo H; Yazaki A; Tanaka K; Shiku H; Yada I
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    LappegÄrd KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anesthetic induction with ketamine inhibits platelet activation before, during, and after cardiopulmonary bypass in baboons.
    Undar A; Eichstaedt HC; Clubb FJ; Lu M; Bigley JE; Deady BA; Porter A; Vaughn WK; Fung M
    Artif Organs; 2004 Oct; 28(10):959-62. PubMed ID: 15385005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study.
    Seghaye MC; Duchateau J; Grabitz RG; Wolff T; Marcus C; Engelhardt W; Hörnchen H; Messmer BJ; von Bernuth G
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):882-92. PubMed ID: 8614150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system.
    Tanhehco EJ; Kilgore KS; Liff DA; Murphy KL; Fung MS; Sun WN; Sun C; Lucchesi BR
    Transplant Proc; 1999 Aug; 31(5):2168-71. PubMed ID: 10456004
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of complement alternative pathway function with anti-properdin monoclonal antibodies.
    Gupta-Bansal R; Parent JB; Brunden KR
    Mol Immunol; 2000 Apr; 37(5):191-201. PubMed ID: 10930626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.